Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices
Abdul-Quddus Kehinde Oyedele, Abdeen Tunde Ogunlana, Ibrahim Damilare Boyenle, et al.
Molecular Diversity (2022) Vol. 27, Iss. 4, pp. 1879-1903
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Perspectives on Computational Enzyme Modeling: From Mechanisms to Design and Drug Development
Kwangho Nam, Yihan Shao, Dan Thomas Major, et al.
ACS Omega (2024)
Open Access | Times Cited: 22
Integrated network pharmacology and in-silico approaches to decipher the pharmacological mechanism of Selaginella tamariscina in the treatment of non-small cell lung cancer
Sunil Kumar, Faheem Abbas, Iqra Ali, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100419-100419
Open Access | Times Cited: 28
Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing
Rama Rao Malla, V Sathiyapriya, Sree Makena, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1463-1463
Open Access | Times Cited: 8
Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations
Mojeed Ayoola Ashiru, Sherif Olabisi Ogunyemi, Oluwakemi Rita Temionu, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 5
Closed Access | Times Cited: 15
UBE2N: Hope on the Cancer Front, How to Inhibit This Promising Target Prospect?
Florian Schwalen, Côme Ghadi, Léonie Ibazizene, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Identification of Small Covalent Inhibitors Targeting DsbA Using Virtual Screening, Covalent Docking, and Molecular Dynamics Simulations
Yuxiang Ren, Ying Xin, Rongxi Zhu, et al.
Journal of Molecular Graphics and Modelling (2025), pp. 109017-109017
Closed Access
Structure-based computational design of novel covalent binders for the treatment of sickle cell disease
Abdeen Tunde Ogunlana, Ibrahim Damilare Boyenle, Taiwo Ooreoluwa Ojo, et al.
Journal of Molecular Graphics and Modelling (2023) Vol. 124, pp. 108549-108549
Closed Access | Times Cited: 10
Review and perspective on bioinformatics tools using machine learning and deep learning for predicting antiviral peptides
Nicolás Lefin, Lisandra Herrera-Belén, Jorge G. Farías, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2365-2374
Closed Access | Times Cited: 9
Molecular docking, QSAR, and ADME studies of some pyrrolo[1, 2-a] benzimidazole-based quinones as novel topoisomerase 2 beta (TOP2β) inhibitors
Rahul D. Jawarkar, Anam.N. Khan, Dhanashri R. Bhagat, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100479-100479
Open Access | Times Cited: 3
Bioinformatics approach for structure modeling, vaccine design, and molecular docking of Brucella candidate proteins BvrR, OMP25, and OMP31
Alyaa Elrashedy, Mohamed Nayel, Akram Salama, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Advancements, challenges, and future frontiers in covalent inhibitors and covalent drugs: A review
Muhammad Salman Hameed, Hongxuan Cao, Li Guo, et al.
European Journal of Medicinal Chemistry Reports (2024), pp. 100217-100217
Open Access | Times Cited: 2
Recent advances in chemometric modelling of inhibitors against SARS-CoV-2
Qianqian Wang, Xinyi Lu, Runqing Jia, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24209-e24209
Open Access | Times Cited: 2
Identification of novel immuno-oncology compounds as VISTA-inhibitors for cancer therapy: A computational approach integrating virtual screening and molecular dynamics simulation
Winner Amaka Egejuru, Olajide Enoch Aderemi, Abel Egbemhenghe, et al.
Informatics in Medicine Unlocked (2024) Vol. 46, pp. 101461-101461
Open Access | Times Cited: 2
bioTCIs: Middle-to-Macro Biomolecular Targeted Covalent Inhibitors Possessing Both Semi-Permanent Drug Action and Stringent Target Specificity as Potential Antibody Replacements
Jay Yang, Yudai Tabuchi, Riku Katsuki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3525-3525
Open Access | Times Cited: 5
Landscape of In Silico Tools for Modeling Covalent Modification of Proteins: A Review on Computational Covalent Drug Discovery
Md. Nazmul Hasan, Manisha Ray, Arjun Saha
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 45, pp. 9663-9684
Closed Access | Times Cited: 5
Integrated Covalent Drug Design Workflow Using Site Identification by Ligand Competitive Saturation
Wenbo Yu, David J. Weber, Alexander D. MacKerell
Journal of Chemical Theory and Computation (2023) Vol. 19, Iss. 10, pp. 3007-3021
Closed Access | Times Cited: 4
Understanding the binding interaction mechanism of i-motif with fluorophores: A biophysical approach
Hibbana Fathima Mohamed Ibrahim, Rupavarshini Manoharan, Bernet Shano Leon, et al.
Chemical Physics Impact (2023) Vol. 7, pp. 100370-100370
Open Access | Times Cited: 4
SUMO E1 covalent allosteric inhibitors modulate polyamine synthesis via the MAT2A-AdoMetDC axis
Shuai Zhang, Zhiying Wang, Yubing Jiao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Computational exploration of molecular flexibility and interaction of meropenem analogs with the active site of oxacillinase-23 in Acinetobacter baumannii
Balajee Ramachandran, Muthupandian Saravanan, Jeyaraman Jeyakanthan, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 2
Antimicrobial, antioxidant and cytotoxic activities of the leaf and stem extracts of Carissa bispinosa used for dental health care
Wanda Shekwa, Tsolanku Sidney Maliehe, Peter Masoko
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
In-silico investigation on the discovery of synthesized nucleoside-based antivirals against monkeypox and SARS-CoV-2 Virus
Thananjeyan Balasubramaniyam, Aparna Ganapathy Vilasam Sreek, Vinod Kumar Nathan, et al.
Research Square (Research Square) (2024)
Open Access
Molecular Docking Assessment of Limonoids from Cameroonian Entandrophragma Species as Potential Inhibitors of Anopheles gambiae Acetylcholinesterase (AChE)
Gervais Mouthé Happi, Sajjad Haider, Sikiru Akinyeye Ahmed, et al.
AppliedChem (2024) Vol. 4, Iss. 4, pp. 320-332
Open Access
New Inhibitors Predicted for Plasmodium Falciparum Erythrocyte Membrane Protein1 (PfEMP1)
Abdul Wahab, Adnan Shehzad, Ayesha Bibi, et al.
TSF journal of biology (2024) Vol. 2, Iss. 2, pp. 20-30
Closed Access
Identification of Novel Organo-Se BTSA-Based Derivatives as Potent, Reversible, and Selective PPARγ Covalent Modulators for Antidiabetic Drug Discovery
Fangyuan Chen, Qingmei Liu, Lei Ma, et al.
Journal of Medicinal Chemistry (2024)
Closed Access
An Integrated Covalent Drug Design Workflow using Site-Identification by Ligand Competitive Saturation
Wenbo Yu, David J. Weber, Alexander D. MacKerell
(2023)
Open Access
Page 1 - Next Page

Scroll to top